HPV Vaccine (Gardasil)
WHAT DOES THE HPV VACCINE DO?
“The HPV vaccine (Gardasil 9) is supposed to prevent nine ‘human papillomavirus’ (HPV) types that can lead to 70% of cervical cancers in females, and to some HPV-causing cancers in males.”
GARDASIL VACCINE ON TRIAL
“Kennedy described a series of fraudulent gimmicks employed by Merck to deceive regulators during the clinical trials including the use of a ‘spiked’ extremely toxic AAHS placebo rather than a true inert placebo that is standard for control groups in blue ribbon safety studies for other pharmaceutical products.”
TESTING CONCERNS
“Merck and GlaxoSmithKline, the manufacturers, did not have to prove that the vaccines prevent cancer. They were allowed to use precancerous lesions as “surrogate endpoints” in the clinical trials. Scientists do not know if a decline in cases of precancerous lesions will translate into fewer cases of cervical cancer in 20-30 years.”
SERIOUS SAFETY CONCERNS
“The potential significance of a case series of adolescents with idiopathic premature ovarian insufficiency following HPV vaccination presenting to a general practice warrants further research. Preservation of reproductive health is a primary concern in the recipient target group.”
WHAT IS IN THE HPV VACCINE?
“amorphous aluminum hydroxyphosphate sulfate, sodium chloride, L-histidine, polysorbate 80, sodium borate, yeast protein”
MARKETING CONCERNS
“Merck focused on mandating immunization, which brought the coercive power of the state to bear on children and parents. Some respondents found it unseemly that Merck stood to profit from a ‘sweetheart deal’ for a mandate or that legislators, in restricting individual liberty, would be influenced by a company with a financial interest in the legislation.”
Related Articles:
